1 – 20 of 28
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A non-invasive 25-Gene PLNM-Score urine test for detection of prostate cancer pelvic lymph node metastasis
2024) In Prostate Cancer and Prostatic Diseases(
- Contribution to journal › Article
- 2021
-
Mark
Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Impact of Cernitin™ on induced chronic prostatitis in animal model for understanding management of lower urinary tract symptoms
(
- Contribution to journal › Article
- 2020
-
Mark
Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up
(
- Contribution to journal › Article
- 2019
-
Mark
The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia : An in vitro study
(
- Contribution to journal › Article
- 2016
-
Mark
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells
(
- Contribution to journal › Article
- 2015
-
Mark
Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions.
(
- Contribution to journal › Article
- 2014
-
Mark
AKT and AMPK Activation after High-Fat and High-Glucose In Vitro Treatment of Prostate Epithelial Cells.
(
- Contribution to journal › Article
- 2013
-
Mark
Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.
(
- Contribution to journal › Article
-
Mark
Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Expression and localization of serotonin receptors in human breast cancer.
(
- Contribution to journal › Article
- 2012
-
Mark
Regional distribution of neuroendocrine cells in the urogenital duct system of the male rat
(
- Contribution to journal › Article
-
Mark
Expression of Serotonin Receptors 5-HT1A, 5-HT1B, 5-HT2B and 5-HT4 in Ovary and in Ovarian Tumours.
(
- Contribution to journal › Article
- 2011
-
Mark
C-JUN INTERVENES WITH DOCETAXEL THERAPY IN CASTRATION-RESISTANT PROSTATE CANCER: AR STILL MATTERS
2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.294-294(
- Contribution to journal › Published meeting abstract
-
Mark
Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
(
- Contribution to journal › Article
- 2010
-
Mark
Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model.
(
- Contribution to journal › Article
- 2009
-
Mark
CYCLIN A1 MEDIATES DRUG-RESISTANT METASTATIC SPREAD OF PCA CELLS IN XENOGRAFTS IN VIVO
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.343-343(
- Contribution to journal › Published meeting abstract
-
Mark
The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models.
(
- Contribution to journal › Article
- 2008
-
Mark
Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
(
- Contribution to journal › Article
-
Mark
Intermittent DHT administration enhances effect of docetaxel in a xenograft model by modulation of ER beta, AR and NEK2
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.278-278(
- Contribution to journal › Published meeting abstract